SpineGuard specializes in the design, development, and marketing of medical devices intended to improve the safety of spinal surgery. The group is developing DSG® digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and "smart" drills. SpineGuard is extending the applications of its DSG® technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
30/10/26	€0.0910	-.--%	169,049
29/10/26	€0.0910	+4.00%	268,589
28/10/26	€0.0875	+1.74%	136,471
27/10/26	€0.0860	-.--%	97,178
26/10/26	€0.0860	+0.12%	107,781

Real-time Euronext Paris

More quotes

Market Closed - Euronext Paris 16:55:00 30/10/2026 GMT			5-day change	1st Jan Change
0.0910 ^EUR	-.--%		+5.94%	-9.90%

10-08	SpineGuard: Revenue Down, but Volumes Up
10-08	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Third Quarter and Nine Months of 2026	CI

Market Cap	8.82M 9.84M 8.12M 7.35M 13.74M 934M 13.98M 96.64M 38.68M 491M 36.91M 36.12M 1.55B	P/E 2024	-3.63x	P/E 2025	-3.37x
Enterprise Value	8.55M 9.54M 7.87M 7.12M 13.33M 906M 13.56M 93.74M 37.52M 476M 35.8M 35.03M 1.5B	EV / Sales 2024	2.94x	EV / Sales 2025	2.33x
Free-Float	97.13%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Euronext Paris	ALSGD	Real-time
Deutsche Boerse AG	6W5	Delayed
Börse Stuttgart	6W5	Delayed
Boerse Muenchen	6W5	Real-time

10-08	SpineGuard: Revenue Down, but Volumes Up
10-08	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Third Quarter and Nine Months of 2026	CI
10-05	Weekly earnings calendar: PepsiCo kicks off the quarterly marathon
09-09	SpineGuard SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09-09	SpineGuard says it can cover its funding needs through the second quarter of 2027
09-04	Weekly earnings calendar: Oracle vs Adobe, a battle of old hands
08-25	SpineGuard Wins US Patent for Robotic Ultrasound Technology	MT
08-24	Spineguard Obtains New U.S. Patent for Innovative Ultrasound Technology Designed to Determine Entry Point and Pedicular Drilling Trajectory	CI
08-24	SpineGuard lands a new US patent in spinal guidance
07-28	SpineGuard, Omnia Medical Obtain New US Patent for Dynamic Surgical Guidance Technology	MT
07-27	SpineGuard And Omnia Medical Obtain Notice Of Allowance For U.S. Patent Application For Innovative Application Of DSG Technology To Sacroiliac Joint Fusion	CI
07-27	SpineGuard Secures a New Patent in the United States
07-08	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Second Quarter and First Half of 2026	CI

SpineGuard Share Price

Stocks

ALSGD

FR0011464452

Medical Equipment, Supplies & Distribution

Valuation: SpineGuard

Chart: SpineGuard

Latest news: SpineGuard

Analysts' recommendations: SpineGuard

Press Releases: SpineGuard

News in other languages: SpineGuard

Quotes and Performance

Price Extremes

Managers and Directors: SpineGuard

Medical Equipment

Financials

Company Profile

Quotes

10-08	SpineGuard Announces Its Q3 Revenue	BU
09-09	SpineGuard Reports 2026 Half-Year Results	BU
08-24	SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory	BU
07-27	SpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint Fusion	BU
07-08	SpineGuard Announces its H1 2026 Revenue	BU

10-09	Bourse : ça bouge chez Saint-Laurent (Kering) et BNP Paribas, SpaceX s'attaque aux opérateurs mobiles
10-09	OpenAI plombe l'ambiance et le Nasdaq
10-08	SpineGuard : chiffre d'affaires en baisse, mais volumes en hausse
10-08	SpineGuard annonce son chiffre d’affaires du troisième trimestre 2026
10-07	Agenda Zonebourse des résultats de sociétés : le 8 octobre 2026

1 week	+5.94%
Current month	+1.11%
1 month	+1.11%
3 months	+8.98%
6 months	-6.09%
Current year	-9.90%

1 week	0.08	0.09
1 month	0.08	0.09
Current year	0.08	0.14
1 year	0.08	0.18
3 years	0.08	0.41
5 years	0.08	1.67
10 years	0.08	5.27

Manager	Title	Age	Since
Stéphane Bette CEO	Chief Executive Officer	-	12/07/2017
Pierre Jérôme CEO	Chief Executive Officer	-	14/02/2020
Anne-Charlotte Millard DFI	Director of Finance/CFO	-	31/12/2008

Director	Title	Age	Since
Stéphane Bette BRD	Director/Board Member	-	15/01/2009
Maurice Bourlion BRD	Director/Board Member	-	01/07/2009
Pierre Jérôme CHM	Chairman	-	28/02/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SPINEGUARD	-.--%	+5.94%	-16.51%	-65.60%	9.84M
ABBOTT LABORATORIES	+1.56%	+2.41%	-14.82%	+14.19%	184B
STRYKER CORPORATION	-6.38%	-4.98%	-20.90%	+11.15%	112B
MEDTRONIC PLC	-0.59%	+1.18%	+6.12%	+37.97%	118B
ESSILORLUXOTTICA	+3.42%	+1.71%	-42.32%	+9.52%	94.58B
CENCORA, INC.	+0.09%	-0.05%	-3.04%	+78.44%	63.13B
HOYA CORPORATION	-0.46%	+0.42%	+8.19%	+82.97%	55.66B
BECTON, DICKINSON AND COMPANY	-0.23%	-0.52%	+10.31%	-21.19%	53.9B
IDEXX LABORATORIES, INC.	-4.30%	-1.64%	-12.30%	+39.06%	43.42B
ALCON INC.	+0.58%	+2.00%	-1.07%	-6.43%	34.68B
Average	-0.63%	+0.65%	-8.63%	+18.01%	75.93B
Weighted average by Cap.	-0.49%	+0.23%	-10.66%	+25.21%

	2024	2025
Net sales	4.65M 5.19M 4.28M 3.87M 7.25M 492M 7.37M 50.96M 20.39M 259M 19.46M 19.05M 816M	3.76M 4.19M 3.46M 3.13M 5.86M 398M 5.96M 41.19M 16.49M 209M 15.73M 15.4M 660M
Net income	-3.08M -3.44M -2.84M -2.57M -4.8M -327M -4.89M -33.79M -13.52M -172M -12.9M -12.63M -541M	-2.07M -2.31M -1.9M -1.72M -3.22M -219M -3.28M -22.67M -9.07M -115M -8.66M -8.47M -363M
Net Debt	1.82M 2.03M 1.67M 1.52M 2.84M 193M 2.88M 19.94M 7.98M 101M 7.62M 7.45M 319M	-265K -296K -244K -221K -414K -28.11M -421K -2.91M -1.16M -14.79M -1.11M -1.09M -46.61M